The company isn't content with just one area of focus; it's actively expanding into new verticals like injectables, peptides, ...

Aurobindo, that last year signed a deal with U.S. drugmaker MSD to manufacture one of their biologics products at its ...

Aurobindo Pharma has terminated a license agreement through its subsidiary Auro Vaccines with Hilleman Laboratories for ...

Hyderabad: Aurobindo Pharma has announced that Auro Vaccines Private Limited, a wholly owned step-down subsidiary of the ...

Aurobindo Pharma has terminated its licensing agreement with Hilleman Laboratories Singapore for a paediatric pentavalent ...

Aurobindo Pharma's subsidiary Auro Vaccines has terminated a license agreement with Singapore-based Hilleman Laboratories for ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Aurobindo Pharma Ltd is quoting at Rs 1104, down 1% on the day as on 13:19 IST on the NSE. The stock jumped 5.96% in last one year as compared to a 2.05% rally in NIFTY and a 7.76% spurt in the Nifty ...

India exported drugs worth around $8.73 billion to the US — about 31 percent of its total pharma exports, while the US exported $635.37 million worth of pharmaceuticals to India.

Aurobindo Pharma Ltd share price was down by -0.23% from the previous closing price of ₹1,093.20. Who are peers of Aurobindo Pharma Ltd? The peers of Aurobindo Pharma Ltd are Sun Pharmaceuticals ...